Charles Schwab Investment Management Inc Supernus Pharmaceuticals, Inc. Transaction History

Charles Schwab Investment Management Inc

  • $601 Billion
  • Q3 2025

A detailed history of Charles Schwab Investment Management Inc transactions in Supernus Pharmaceuticals, Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 732,489 shares of SUPN stock, worth $33 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
732,489
Previous 748,641 2.16%
Holding current value
$33 Million
Previous $23.6 Million 48.35%
% of portfolio
0.01%
Previous 0.0%

Shares

34 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 10, 2025
SELL
$31.45 - $47.79 $507,980 - $771,904
-16,152 Reduced 2.16%
732,489 $35 Million
Q2 2025

Aug 12, 2025
BUY
$30.29 - $33.43 $75,482 - $83,307
2,492 Added 0.33%
748,641 $23.6 Million
Q1 2025

Sep 15, 2025
SELL
$31.17 - $40.0 $77,675 - $99,680
-2,492 Reduced 0.33%
746,149 $24.4 Million
Q1 2025

May 09, 2025
SELL
$31.17 - $40.0 $224,860 - $288,560
-7,214 Reduced 0.96%
746,149 $24.4 Million
Q4 2024

Feb 06, 2025
BUY
$31.89 - $37.83 $1.31 Million - $1.55 Million
40,968 Added 5.75%
753,363 $27.2 Million
Q3 2024

Nov 12, 2024
BUY
$25.77 - $35.16 $2.35 Million - $3.21 Million
91,354 Added 14.71%
712,395 $22.2 Million
Q2 2024

Aug 12, 2024
BUY
$25.99 - $33.85 $737,986 - $961,170
28,395 Added 4.79%
621,041 $16.6 Million
Q1 2024

May 08, 2024
BUY
$27.11 - $35.17 $995,370 - $1.29 Million
36,716 Added 6.6%
592,646 $20.2 Million
Q4 2023

Feb 06, 2024
BUY
$22.72 - $29.68 $560,820 - $732,621
24,684 Added 4.65%
555,930 $16.1 Million
Q3 2023

Nov 08, 2023
SELL
$27.57 - $32.91 $310,493 - $370,632
-11,262 Reduced 2.08%
531,246 $14.6 Million
Q2 2023

Aug 09, 2023
BUY
$29.91 - $38.73 $978,116 - $1.27 Million
32,702 Added 6.41%
542,508 $16.3 Million
Q1 2023

May 11, 2023
BUY
$34.93 - $42.03 $82,260 - $98,980
2,355 Added 0.46%
509,806 $18.5 Million
Q4 2022

Feb 13, 2023
BUY
$31.09 - $37.88 $1.23 Million - $1.5 Million
39,677 Added 8.48%
507,451 $18.1 Million
Q3 2022

Nov 14, 2022
BUY
$28.79 - $35.41 $1.1 Million - $1.36 Million
38,323 Added 8.92%
467,774 $15.8 Million
Q2 2022

Aug 15, 2022
BUY
$25.33 - $34.25 $687,988 - $930,264
27,161 Added 6.75%
429,451 $12.4 Million
Q1 2022

May 13, 2022
BUY
$28.51 - $32.9 $946,474 - $1.09 Million
33,198 Added 8.99%
402,290 $13 Million
Q4 2021

Feb 11, 2022
BUY
$26.37 - $34.22 $186,884 - $242,517
7,087 Added 1.96%
369,092 $10.8 Million
Q3 2021

Nov 16, 2021
SELL
$23.54 - $31.39 $1.33 Million - $1.77 Million
-56,535 Reduced 13.51%
362,005 $9.66 Million
Q2 2021

Aug 16, 2021
SELL
$26.72 - $33.19 $865,434 - $1.07 Million
-32,389 Reduced 7.18%
418,540 $12.9 Million
Q1 2021

May 17, 2021
BUY
$24.15 - $31.45 $276,082 - $359,536
11,432 Added 2.6%
450,929 $11.8 Million
Q4 2020

Feb 16, 2021
SELL
$17.7 - $25.81 $127,740 - $186,270
-7,217 Reduced 1.62%
439,497 $11.1 Million
Q3 2020

Nov 13, 2020
BUY
$20.2 - $25.05 $2.09 Million - $2.6 Million
103,632 Added 30.21%
446,714 $9.31 Million
Q2 2020

Aug 14, 2020
BUY
$17.09 - $24.89 $392,010 - $570,926
22,938 Added 7.16%
343,082 $8.15 Million
Q1 2020

May 15, 2020
SELL
$14.45 - $24.69 $1.23 Million - $2.1 Million
-85,224 Reduced 21.02%
320,144 $5.76 Million
Q4 2019

Feb 07, 2020
BUY
$19.93 - $29.13 $125,957 - $184,101
6,320 Added 1.58%
405,368 $9.62 Million
Q3 2019

Nov 08, 2019
BUY
$25.47 - $33.37 $1.08 Million - $1.41 Million
42,324 Added 11.86%
399,048 $11 Million
Q2 2019

Aug 09, 2019
BUY
$29.96 - $38.87 $799,542 - $1.04 Million
26,687 Added 8.09%
356,724 $11.8 Million
Q1 2019

May 14, 2019
BUY
$32.77 - $41.99 $404,676 - $518,534
12,349 Added 3.89%
330,037 $11.6 Million
Q4 2018

Feb 14, 2019
BUY
$30.84 - $49.51 $187,784 - $301,466
6,089 Added 1.95%
317,688 $10.6 Million
Q3 2018

Nov 13, 2018
BUY
$42.7 - $56.55 $1.01 Million - $1.34 Million
23,662 Added 8.22%
311,599 $15.7 Million
Q2 2018

Aug 08, 2018
SELL
$44.1 - $59.85 $1.26 Million - $1.71 Million
-28,509 Reduced 9.01%
287,937 $17.2 Million
Q1 2018

May 07, 2018
BUY
$37.15 - $46.9 $1.13 Million - $1.43 Million
30,443 Added 10.64%
316,446 $14.5 Million
Q4 2017

Jan 17, 2018
BUY
$36.4 - $42.6 $1.77 Million - $2.08 Million
48,732 Added 20.54%
286,003 $11.4 Million
Q3 2017

Nov 13, 2017
BUY
$36.75 - $49.65 $8.72 Million - $11.8 Million
237,271
237,271 $9.49 Million

Others Institutions Holding SUPN

# of Institutions
330
Shares Held
60.2M
Call Options Held
234K
Put Options Held
0
View Full List

About SUPERNUS PHARMACEUTICALS, INC.

SUPN Quotes by TradingView
  • Ticker SUPN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 53,495,300
  • Market Cap $2.41B
  • Description
  • Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States. Its commercial products are Trokendi XR, an extended release topiramate product indicated for the treatment of epilepsy, as well as for the prop...
More about SUPN
Track This Portfolio

Track Charles Schwab Investment Management Inc Portfolio

Follow Charles Schwab Investment Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Charles Schwab Investment Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email